Split History
ETFs Holding NRCIB »    NRCIB Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
National Research is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations. Co.'s solutions enable its clients to provide healthcare through understanding the voice of the customer, while facilitating regulatory compliance and the shift to population-based health management. Co.'s portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of constituent-related elements, including patient experience and physician engagement. According to our NRCIB split history records, NRCIB has had 1 split.
NRCIB split history picture
NRCIB (NRCIB) has 1 split in our NRCIB split history database. The split for NRCIB took place on May 23, 2013. This was a 7 for 2 split, meaning for each 2 shares of NRCIB owned pre-split, the shareholder now owned 7 shares. For example, a 1000 share position pre-split, became a 3500 share position following the split.

When a company such as NRCIB splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the NRCIB split history from start to finish, an original position size of 1000 shares would have turned into 3500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NRCIB shares, starting with a $10,000 purchase of NRCIB, presented on a split-history-adjusted basis factoring in the complete NRCIB split history. NRCIB split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 03/07/2011
End date: 04/17/2018
Start price/share: $9.29
End price/share: $53.01
Starting shares: 1,076.43
Ending shares: 1,468.82
Dividends reinvested/share: $10.12
Total return: 678.62%
Average Annual Total Return: 33.44%
Starting investment: $10,000.00
Ending investment: $77,878.70
Years: 7.12
Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2011
End date: 04/17/2018
Start price/share: $9.29
End price/share: $53.01
Dividends collected/share: $10.12
Total return: 579.58%
Average Annual Total Return: 30.91%
Starting investment: $10,000.00
Ending investment: $67,962.55
Years: 7.12
Date Ratio
05/23/20137 for 2
NRCIB is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NSPH Split History
NSPR Split History
NURO Split History
NVAX Split History
NVGN Split History
NVIV Split History
NVLS Split History
NVO Split History
NVUS Split History
NWBO Split History

Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
Exela Technologies, Inc. (XELA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NRCIB Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.